AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23461009
Drug: Reamberin 1.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reamberin 1.5% infusion
Trial: 23461009
Drug: Official therapy
RxNorm normalized name: Fumaria officials whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Official therapy
Trial: 15687942
Drug: Amoxicillin +
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin + clavulanic acid 1g/125 mg administered from ovum pick-up day for 6 days
Trial: 9450157
Drug: pivagabine (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivagabine (900 mg/d)
Trial: 7949210
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg 4-hydroxyandrostenedione i.m. fortnightly
Trial: 7949210
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg 4-hydroxyandrostenedione i.m. fortnightly
Trial: 3048754
Drug: Propofol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.5 mg.kg‐1 IV
Trial: 3048754
Drug: Thiopentone 5
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 5 mg.kg‐1 IV
Trial: 28453754
Drug: Once-daily mesalazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily mesalazine
Trial: 28453754
Drug: Twice-daily mesalazine
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily mesalazine
Trial: 18817348
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (oral hydrochloric acid sertraline, local inunction of traditional Chinese medicine, guidance in sexual psychology and knowledge)
Trial: 18817348
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral hydrochloric acid sertraline only)
Trial: 11944739
Drug: Selegiline, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline, 5 mg, twice a day for 3 months
Trial: 20973966
Drug: Fenofibrate (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (300 mg/day for 25 weeks)
Trial: 12010234
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for penile fracture
Trial: 10660868
Drug: Ginseng (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginseng (n = 7), receiving 350 mg of ginseng daily for 6 weeks
Trial: 10660868
Drug: Placebo (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (n = 8), receiving a placebo daily for 6 weeks
Trial: 7848024
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg twice daily vs Losartan 100 mg once daily
Trial: 7848024
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg once daily vs Losartan 50 mg twice daily
Trial: 7848024
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of hydrochlorothiazide 12.5 mg/d
Trial: 367153
Drug: Low-calcium meal
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calcium meal (100 mg)
Trial: 367153
Drug: High-calcium meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-calcium meal (400 mg)
Trial: 31795748
Drug: Complex decongestive
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex decongestive treatment (n=38)
Trial: 31795748
Drug: Complex decongestive
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex decongestive treatment + intermittent pneumatic compression (n=38)
Trial: 31134436
Drug: No laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No laser treatment
Trial: 23370739
Drug: Pramipexole added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole added to current medications
Trial: 23370739
Drug: Switching from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switching from ergot dopamine agonist to pramipexole
Trial: 21081553
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PTFE membrane and synthetic PEG
Trial: 785019
Drug: Antacid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid therapy
Trial: 785019
Drug: No antacid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antacid therapy
Trial: 31246632
Drug: Enteral plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral plus Total Parenteral Nutrition (EN+TPN)
Trial: 17874717
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTA) and physical therapy
Trial: 11721321
Drug: OCA 1
RxNorm normalized name: STARCH, TAPIOCA 15.81 g in 100 mL TOPICAL CREAM [GZE Man Ball Deodorant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCA 1 (omeprazole 20 mg, clarithromycin 500 mg, amoxicillin 1000 mg, twice daily for one week)
Trial: 11721321
Drug: OCA 2
RxNorm normalized name: Avoca 25 % / 75 % Medicated Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCA 2 (omeprazole 20 mg, clarithromycin 500 mg, amoxicillin 1000 mg, twice daily for two weeks)
Trial: 11721321
Drug: OCM (omeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCM (omeprazole 20 mg, clarithromycin 500 mg, metronidazole 500 mg, twice daily for one week)
Trial: 9248896
Drug: Liquid nitrogen
DrugBank: Nitrogen (DB09152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liquid nitrogen therapy
Trial: 9248896
Drug: Other known
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other known treatment modalities
Trial: 2889555
Drug: Vecuronium (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (60 micrograms/kg bolus + 1 microgram/min/kg infusion) with halothane anesthesia
Trial: 2889555
Drug: Vecuronium (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (60 micrograms/kg bolus + 1 microgram/min/kg infusion) with fentanyl anesthesia
Trial: 30152527
Drug: SENS-111 (100-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SENS-111 (100-500 mg single doses; 50-150 mg/day for 4 days; 200-250 mg/day for 7 days)
Trial: 30152527
Drug: SENS-111 (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SENS-111 (100-200 mg/day)
Trial: 23982695
Drug: Lyophilized black
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lyophilized black raspberries (BRBs) 45 g/d for 4 days followed by HFHC breakfast with BRBs
Trial: 20966375
Drug: Standard Shape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Shape Up RI program plus video lessons, daily self-monitoring of weight, eating, and exercise, and computer-generated feedback (Study 2)
Trial: 705282
Drug: Traditional physiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional physiotherapy treatment (1 hour/day)
Trial: 25959558
Drug: Prasugrel 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60 mg loading dose followed by 10 mg daily maintenance dose (n=19)
Trial: 25959558
Drug: Ticagrelor 180
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 180 mg loading dose followed by 90 mg twice daily maintenance dose (n=20)
Trial: 23746674
Drug: Concurrent chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiation (CRT) to a dose of 66 Gy in 33 fractions over 6.5 weeks with concurrent cisplatin (100 mg/m(2) on days 1, 22 and 43)
Trial: 23746674
Drug: Accelerated radiotherapy
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated radiotherapy with concomitant boost (CBRT) to a dose of 67.5 Gy in 40 fractions over 5 weeks
Trial: 16734237
Drug: Piroxicam 40
RxNorm normalized name: piroxicam 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 40 mg IM
Trial: 16734237
Drug: Tramadol 100
RxNorm normalized name: tramadol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 100 mg IV
Trial: 8428787
Drug: Usual alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Usual alcohol drinking (self-reported 56.1 +/- 3.6 ml/day)
Trial: 28200002
Drug: AbobotulinumtoxinA solution
RxNorm normalized name: abobotulinumtoxinA
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: AbobotulinumtoxinA solution for injection (ASI) 20 U
Trial: 28200002
Drug: AbobotulinumtoxinA solution
RxNorm normalized name: abobotulinumtoxinA
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: AbobotulinumtoxinA solution for injection (ASI) 75 U
Trial: 25455987
Drug: MVA-H5-sfMR vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA-H5-sfMR vaccine at 10^8 pfu
Trial: 25455987
Drug: MVA-H5-sfMR vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA-H5-sfMR vaccine at 10^7 pfu
Trial: 22928785
Drug: Danusertib 330
RxNorm normalized name: Danusertib
DrugBank: Danusertib (DB11778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danusertib 330 mg/m2 over 6 h i.v. on days 1, 8 and 15 (arm A)
Trial: 22928785
Drug: Danusertib 500
RxNorm normalized name: Danusertib
DrugBank: Danusertib (DB11778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danusertib 500 mg/m2 over 24 h i.v. on days 1 and 15 (arm B)
Trial: 19887460
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (10 mg/kg/day for the first 14 days)
Trial: 18704249
Drug: Tolterodine tartrate
RxNorm normalized name: Tolterodine Tartrate
DrugBank: Tolterodine (DB01036)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tolterodine tartrate extended-release capsules 4 mg
Trial: 18704249
Drug: Tolterodine tartrate
RxNorm normalized name: Tolterodine Tartrate
DrugBank: Tolterodine (DB01036)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tolterodine tartrate extended-release capsules 4 mg with behavioral therapy
Trial: 15752098
Drug: n-butanol solutions
RxNorm normalized name: BUTANOLS
DrugBank: Butyl alcohol (DB02145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-butanol solutions (0 to 90,000 ppm)
Trial: 8779366
Drug: 2000 ml
RxNorm normalized name: TPN Bag 2000 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 ml of Ringer lactate solution (crystalloid group)
Trial: 8779366
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml of 6% hydroxyethyl starch + 1000 ml of Ringer lactate solution (colloid group)
Trial: 1738219
Drug: Albumin supplementation
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin supplementation with total parenteral nutrition
Trial: 1738219
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (control group)
Trial: 6720727
Drug: Thiazide/propranolol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide/propranolol combination
Trial: 28945652
Drug: Nonpreserved 0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpreserved 0.9% NaCl commercial saline solution
Trial: 27165064
Drug: Tyrosine kinase
RxNorm normalized name: Protein-tyrosine kinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tyrosine kinase inhibitor Votrient
Trial: 27165064
Drug: mTOR blocker
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mTOR blocker Afinitor
Trial: 23359971
Drug: Chinese medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medical syndrome typing and treatment combined cold needle puncture drainage operation
Trial: 23359971
Drug: Chinese medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medical syndrome typing and treatment combined unipolar electrocoagulation drilling technique
Trial: 7530173
Drug: Cisplatin 50
RxNorm normalized name: cisplatin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 50 mg/m2 in weeks 1 and 2, IFN 5 MU/m2 per day on days 1-5 in week 1, 5-FU 800 mg/m2 per day for 5 days, HU 500 mg every 12 h for 11 doses during week 2
Trial: 7530173
Drug: Cisplatin 100
RxNorm normalized name: CISPLATIN 100MG/VIL (PF) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 100 mg/m2 during weeks 1 and 2, IFN 2.5 MU/m2 per day
Trial: 7530173
Drug: Hyperfractionated radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiotherapy (150 cGy twice daily during weeks 1 and 2)
Trial: 7530173
Drug: Chemotherapy doses
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy doses during hyperfractionated radiotherapy
Trial: 30767961
Drug: Web-based educational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based educational intervention with tailored messages and quarterly data on hazardous drug spills
Trial: 18081224
Drug: Contrast-enhanced ultrasound
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast-enhanced ultrasound with SonoVue (bolus injection 2.5 mL)
Trial: 16741726
Drug: Temozolomide (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temozolomide (75 mg/m²/day) for 6 weeks followed by a 2-week rest; Thalidomide (200 mg/day) increased by 100 mg/day weekly up to 400 mg/day (or 100 mg/day increased by 50 mg/day for patients >70 years up to 250 mg/day)
Trial: 1883119
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU of vitamin D daily
Trial: 7047256
Drug: guanabenz (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: guanabenz (mean dose, 24 mg/day)
Trial: 7047256
Drug: hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hydrochlorothiazide (50 or 100 mg/day; mean, 70 mg/day)
Trial: 19214338
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein diet (1.2 +/- 0.0 g protein x kg(-1) x d(-1))
Trial: 19214338
Drug: Lower protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower protein diet (0.9 +/- 0.1 g protein x kg(-1) x d(-1))
Trial: 10378391
Drug: Acarbose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (50 mg t.i.d.) for 5 days
Trial: 6134981
Drug: Selenium levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium levels in serum (mean 0.129 +/- SEM 0.002 micrograms/ml)
Trial: 6134981
Drug: Selenium levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium levels in serum (mean 0.136 +/- SEM 0.002 micrograms/ml)
Trial: 30133928
Drug: Fosfomycin trometamol
RxNorm normalized name: trometamol
DrugBank: Tromethamine (DB03754)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin trometamol (FOS) 3 g PO every 10 days + trimethoprim‐sulfamethoxazole (TMP‐SMX, 160/800 mg) three times per week (Group 1)
Trial: 30133928
Drug: Trimethoprim‐sulfamethoxazole (TMP‐SMX,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim‐sulfamethoxazole (TMP‐SMX, 160/800 mg) daily (Group 2)
Trial: 20973220
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy group (N)
Trial: 16039331
Drug: Carboplatin (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (one injection, dose based on the formula 7x[glomerular filtration rate+25] mg; n=573)
Trial: 11942473
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2-8 g)
Trial: 11942473
Drug: Fish meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish meals and fish oil supplements
Trial: 1761810
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 0.6 U/kg/week sc 5‐6 times/week
Trial: 1761810
Drug: Low-dose oxandrolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oxandrolone 0.07 mg/kg po
Trial: 6366806
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg salbutamol 3-times daily
Trial: 6366806
Drug: 20 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms clenbuterol twice daily
Trial: 6366806
Drug: 40 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 micrograms clenbuterol twice daily
Trial: 25098981
Drug: Levamisole (vermisole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (vermisole 150 mg, once daily for the first 3 days of 3 weeks in a month for 3 months with a gap of 1 week)
Trial: 22212648
Drug: pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: pegylated interferon alpha plus ribavirin therapy
Trial: 15498373
Drug: Acupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture and moxibustion (acu‐moxi) in combination with prednisone, Vitamin B1, vitamin B12, and dibazole
Trial: 10694777
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea (2 g tea solids in 300 ml water)
Trial: 1389935
Drug: Sublingual verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual verapamil 40 mg (Securon)
Trial: 1389935
Drug: Oral verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral verapamil 40 mg (Securon)
Trial: 17583595
Drug: Esmolol 1
RxNorm normalized name: esmolol 10 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol 1 mg kg‐1 (Group I, n = 40)
Trial: 17583595
Drug: Magnesium 30
RxNorm normalized name: Magnesium 30mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium 30 mg kg‐1 (Group II, n = 40)
Trial: 12197844
Drug: Naloxone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10 mg twice daily for 8 weeks)
Trial: 12197844
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical capsules for 8 weeks)
Trial: 9451563
Drug: Fine-needle aspiration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fine-needle aspiration (FNA) sampling from 3 sequential regions
Trial: 9451563
Drug: Fine-needle aspiration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fine-needle aspiration (FNA) sampling from 4 sequential regions
Trial: 30773863
Drug: IHTAN +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IHTAN + acupoint injection
Trial: 30773863
Drug: Warm needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm needle moxibustion + acupoint injection
Trial: 20808092
Drug: Home-delivered problem
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home-delivered problem adaptation therapy (PATH)
Trial: 20808092
Drug: Home-delivered supportive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-delivered supportive therapy (ST)
Trial: 17209889
Drug: Spaced education
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spaced education consisting of weekly e-mailed case scenarios and clinical questions on 2 of the 4 urology topics.
Trial: 12934761
Drug: E-Mousse (20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E-Mousse (20% acetate vitamin E) applied twice daily for 3 weeks
Trial: 1913767
Drug: Least thorough
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Least thorough rinsing procedure (5 ml x 2 s once)
Trial: 1913767
Drug: Most thorough
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Most thorough rinsing procedure (20 ml x 10 s twice)
Trial: 6130066
Drug: buspirone (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buspirone (average 16.5 mg/day)
Trial: 6130066
Drug: diazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (15 mg/day)
Trial: 30880505
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg of MYO + 150 mg of DCI twice daily
Trial: 30880505
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg of MYO + 13.8 mg of DCI twice daily
Trial: 26850310
Drug: Weekly nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly nutrition lessons focused on benefits of fruit and vegetable consumption
Trial: 26850310
Drug: Weekly nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly nutrition lessons and provision of one serving of fruits and two servings of vegetables per day for 10 weeks
Trial: 21819279
Drug: Methylphenidate treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate treatment for 10 weeks